Piramal Life Sciences Says No Stake Sale Discussion with Sanofi-Aventis (France)

April 6, 2009 |

1 min read

MUMBAI, April 6 (Reuters) - India Piramal Healthcare Ltd's chairman on Monday said he was not in merger talks with any firm, including Sanofi-Aventis, after a paper reported the French firm's plans to buy Piramal had failed.

Mergers & acquisitions Asia

Sanofi

MORE ON THIS TOPIC

Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.

Cardiovascular disease

Alnylam Unites With Tenaya in Potential $1B+ Pact To Find New Genetic Heart Disease Targets

March 5, 2026

·

2 min read

·

Heather McKenzie

Modern design with a positive context, a handshake. Concept of help, support and harmony between adults. Modern art collage, trendy magazine style.

Collaboration

Roche Broadens Global Clinical Trial Footprint With $480M+ South Korea Pledge

March 5, 2026

·

1 min read

·

Tristan Manalac

Businessman receiving large stacks of money from a giant hand. Concept of funding, venture capital, financial support, dividend, and profitable business.

Funding

Teva Bags $400M Backing From Blackstone To Advance Sanofi-Partnered Drug

March 4, 2026

·

2 min read

·

Tristan Manalac

Reaching an agreement. Businessmen shake hands and make a deal. vector

Immunology and inflammation

Sanofi Bets Up to $1.53B in Hong Kong Immuno Pact, Adding to String of Deals

March 4, 2026

·

2 min read

·

Tristan Manalac